Coston McIsaac & Partners’s Organon & Co OGN Stock Holding History

Coston McIsaac & Partners’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5K	Hold	372	–	–	﹤0.01%	678
2026 Q1	$2K	Hold	372	–	–	﹤0.01%	763
2025 Q4	$2K	Sell	372 -448	-55%	-$3.54K	﹤0.01%	750
2025 Q3	$8K	Hold	820	–	–	﹤0.01%	579
2025 Q2	$7K	Sell	820 -36	-4%	-$371	﹤0.01%	575
2025 Q1	$12K	Hold	856	–	–	﹤0.01%	474
2024 Q4	$12K	Sell	856 -25	-3%	-$407	﹤0.01%	463
2024 Q3	$16K	Sell	881 -10	-1%	-$207	﹤0.01%	431
2024 Q2	$18K	Sell	891 -114	-11%	-$2.27K	0.01%	391
2024 Q1	$18K	Buy	1,005 +1	+0.1%	+$17	0.01%	400
2023 Q4	$14K	Buy	1,004 +1	+0.1%	+$14	﹤0.01%	436
2023 Q3	$17K	Buy	1,003 +1	+0.1%	+$21	0.01%	399
2023 Q2	$20K	Hold	1,002	–	–	0.01%	405
2023 Q1	$23K	Buy	1,002 +35	+4%	+$940	0.01%	383
2022 Q4	$27K	Buy	967 +1	+0.1%	+$26	0.01%	370
2022 Q3	$22K	Sell	966 -8	-0.8%	-$242	0.01%	324
2022 Q2	$33K	Buy	+974	New	+$34.1K	0.02%	169

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Coston McIsaac & Partners's OGN Position: Q2 2026 in Review

Coston McIsaac & Partners held its Organon & Co (OGN) position steady in Q2 2026 at 372 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #678.

Coston McIsaac & Partners first reported a position in OGN in Q2 2022 and has held it in 17 quarters since. The position peaked at $33K in Q2 2022. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

Coston McIsaac & Partners held 372 shares of Organon & Co worth $5K as of Q2 2026.
Coston McIsaac & Partners left its Organon & Co share count unchanged in Q2 2026.
Organon & Co made up ﹤0.01% of Coston McIsaac & Partners's portfolio in Q2 2026, its #678 holding.
Coston McIsaac & Partners first reported a position in Organon & Co in Q2 2022 and has held it in 17 quarters since.
Coston McIsaac & Partners's Organon & Co position peaked at $33K in Q2 2022.
631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Coston McIsaac & Partners's 13F filing for Q2 2026, filed 12 Aug 2026.